Eucerin’s Thiamidol-containing face care collection is finally making its long-awaited US debut, promoted as reducing the appearance of dark spots over time and improving skin radiance in as little as two weeks, according to Stamford, Conn.-based Beiersdorf, Inc.
Eucerin Thiamidol-Backed Face Care For Hyperpigmentation Debuts Stateside
Eucerin Radiant Tone Collection comprises five products centered on the brand’s wildly popular ingredient Thiamidol, currently the most effective inhibitor of human tyrosinase, an enzyme that contributes to skin hyperpigmentation.
More from New Products
• By
RoC launches RoC 35 Protocol, a five-product regimen backed by the brand’s largest clinical assessment yet, showing 200 subjects saw significant improvement in ‘key parameters’ of skin aging.
• By
Church & Dwight Co. Inc. will launch a new body acne patch under its Hero Mighty Patch range, a light dry shampoo formula for Batiste and three new initiatives for vitafusion gummies, the firm reported during its Analyst Day 31 January.
• By
Eucerin Radiant Tone Collection comprises five products centered on the brand’s wildly popular ingredient Thiamidol, currently the most effective inhibitor of human tyrosinase, an enzyme that contributes to skin hyperpigmentation.
• By
Target Corp. expands affordable wellness offerings in 2025 with 2,000 new items, including personal care and beauty. Separately, Coty Inc.’s Rimmel London brand launches Wonder Bond Bonding Serum Mascara and Covergirl introduces Lash Blast Supercloud Mascara featuring an ‘air-whipped’ emulsion formula; US Beauty Launch News.
More from HBW Insight
• By
Kim Kardashian lifestyle company SKIMS buys back rights to SKKN by Kim from Coty, Inc., which had purchased a 20% interest in the brand in 2020 for $200m. Separately, NYX Professional Makeup partners with Warner Bros. to launch the “A Minecraft Movie” collection.
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
• By
US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.